- Home
- / Actinogen Medical
- / Financials
Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.
Actinogen Medical financials data including stock price, CreditSafe score, income statement, balance sheet, and cash flow.
Stock Price
$0
2024-10-04
Market Capitalization
$76.6 M
2024-10-04
CreditSafe Score
?
Score changed on Jun 10, 2026
Premium Content only available in Craft’s Intelligence Portal
View 30+ financial ratio metrics including price-to-earnings ratio, debt-to-assets ratio, gross profit margin, and more.
Financial ratio metrics help evaluate the financial strength of a company, and help raise red flags that can indicate potential risk, fulfillment challenges, or even possible bankruptcy.
Learn moreFinancial Statements
| AUD | FY, 2018 | FY, 2019 | FY, 2020 | FY, 2021 | FY, 2022 | FY, 2023 | FY, 2024 | FY, 2025 |
|---|---|---|---|---|---|---|---|---|
| Gross profit | 3.2M | 4.9M | 3.5M | 2.0M | 3.6M | 4.9M | 9.9M | 5.5M |
| Operating expense total | 9.2M | 14.1M | 8.5M | 5.5M | 12.8M | 15.5M | 22.8M | 20.4M |
| Depreciation and amortization | 357.0K | 354.0K | 413.0K | 387.0K | 401.0K | 406.0K | 417.0K | 422.0K |
| EBITDA | (6.0M) | (9.3M) | (5.0M) | (3.5M) | (9.1M) | (10.6M) | (12.8M) | (14.9M) |
| EBIT | (6.4M) | (9.6M) | (5.4M) | (3.9M) | (9.5M) | (11.0M) | (13.3M) | (15.4M) |
| Interest income | 39.0K | 205.0K | 94.0K | 27.0K | 41.0K | 367.0K | 291.0K | 685.0K |
| Interest expense | 11.0K | 8.0K | 29.0K | 22.0K | 18.0K | 17.0K | 24.0K | 49.0K |
| Pre tax profit | (6.2M) | (9.9M) | (5.3M) | (3.9M) | (9.5M) | (10.8M) | (13.0M) | (14.7M) |
| Net Income | (6.2M) | (9.9M) | (5.3M) | (3.9M) | (9.5M) | (10.8M) | (13.0M) | (14.7M) |